Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
11/1/2000
1.
Phase II Study of Antibiotics and Gastric Acid Inhibition for Gastric MALT Lymphoma (Summary Last Modified 11/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 to 80
NCI
MDA-CPPDM-95084
NCI-T95-0003D, NCT00002682, T95-0003
Last Modified:
4/1/1999
2.
Phase II Trial of Antibiotic Eradication of Helicobacter Pylori and, Failing That, Local Therapy with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) and Involved Field Radiation in Patients with Mucosa Associated Lymphoid Tissue (MALT) Lymphomas (Summary Last Modified 04/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
SWOG-9703
S9703
Last Modified:
5/1/2000
 
First Published:
1/1/1998
3.
Phase II Study of Anti-Helicobacter pylori Treatment in Endoscopically Diagnosed Low Grade Localized Gastric Lymphoma (Summary Last Modified 05/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
EORTC-20961
CRC-EORTC-20961, HOVON-33, NCT00003151
Last Modified:
7/10/2007
 
First Published:
8/19/2005
4.
Randomized Study of Omeprazole and Amoxicillin and/or Vitamin and Mineral Supplementation Comprising Vitamin E, Ascorbic Acid, and Selenium and/or Garlic Supplementation to Inhibit Progression Towards Gastric Cancer in Patients With Precancerous Gastric Lesions
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Prevention
Closed
35 to 65
NCI
NCI-OH-95-C-N029
BICR-OH95-C-N029, NCT00134121
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute